Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.18 USD | -3.20% | +4.95% | -5.92% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.15M | Capitalization | 120M |
---|---|---|---|---|---|
Net income 2024 * | -89M | Net income 2025 * | -109M | EV / Sales 2024 * | - |
Net cash position 2024 * | 47.77M | Net cash position 2025 * | 241M | EV / Sales 2025 * | -105 x |
P/E ratio 2024 * |
-1.56
x | P/E ratio 2025 * |
-1.61
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.79% |
Latest transcript on Vigil Neuroscience, Inc.
1 day | -3.20% | ||
1 week | +4.95% | ||
Current month | +21.84% | ||
1 month | -0.31% | ||
3 months | +2.25% | ||
6 months | -42.50% | ||
Current year | -5.92% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Director of Finance/CFO | 50 | 20-06-30 | |
Kelly Neelon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Mary Thistle
BRD | Director/Board Member | 64 | 22-04-17 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.18 | -3.20% | 79,302 |
24-05-09 | 3.285 | -13.10% | 194,996 |
24-05-08 | 3.78 | +18.50% | 532,046 |
24-05-07 | 3.19 | +10.38% | 52,143 |
24-05-06 | 2.89 | -4.62% | 74,877 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.92% | 120M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- VIGL Stock